Molecure S.A.
Clinical-stage biotech developing small molecule drugs for oncology and fibrotic diseases.
MOC | WAR
Overview
Corporate Details
- ISIN(s):
- PLONCTH00011
- LEI:
- 2594003L11V38ZCVKZ09
- Country:
- Poland
- Address:
- Warszawa Żwirki i Wigury 101, 02-089 Warszawa
- Website:
- https://molecure.com/
Description
Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drugs for diseases with high unmet medical needs. The company utilizes its expertise in medicinal chemistry and biology to identify, validate, and modulate novel protein and mRNA targets. Its therapeutic pipeline is concentrated on oncological, inflammatory, and fibrotic diseases. Molecure operates a proprietary discovery platform for targeting mRNA with small molecules, enabling the development of innovative therapies for previously untreatable conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-28 00:20 |
Podpis biegłego rewidenta
|
Polish | XML • 10.6 KB | ||
| 2025-03-28 00:20 |
SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA ROCZNEGO JEDNOSTKOWEGO S…
|
Polish | XML • 1.6 MB | ||
| 2025-03-28 00:20 |
Podpisy Zarządu pod sprawozdaniem z działalności
|
Polish | XML • 323.2 KB | ||
| 2025-03-28 00:20 |
Sprawozdanie Zarządu z działalności Molecure S.A. za 2024 roku
|
Polish | XML • 6.1 MB | ||
| 2025-03-28 00:20 |
Podpisy Zarządu pod Jednostkowym Raportem Rocznym
|
Polish | XML • 329.3 KB | ||
| 2025-03-28 00:20 |
Jednostkowy Raport Roczny Molecure S.A.
|
Polish | XML • 4.2 MB | ||
| 2025-03-28 00:20 |
List do akcjonariuszy
|
Polish | XML • 515.8 KB | ||
| 2025-03-28 00:18 |
Podpis biegłego rewidenta
|
Polish | XML • 10.6 KB | ||
| 2025-03-28 00:18 |
SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA ROCZNEGO SKONSOLIDOWANEG…
|
Polish | XML • 1.8 MB | ||
| 2025-03-28 00:18 |
Podpisy Zarządu pod sprawozdaniem z działalności
|
Polish | XML • 323.2 KB | ||
| 2025-03-28 00:18 |
Sprawozdanie Zarządu z działalności Molecure S.A. za 2024 roku
|
Polish | XML • 6.1 MB | ||
| 2025-03-28 00:18 |
Podpisy Zarządu podSkonsolidowanym Raportem Rocznym
|
Polish | XML • 329.4 KB | ||
| 2025-03-28 00:18 |
Skonsolidowany Raport Roczny Molecure S.A.
|
Polish | ZIP • 5.0 MB | ||
| 2025-03-28 00:18 |
List do akcjonariuszy
|
Polish | XML • 515.8 KB | ||
| 2025-03-24 11:24 |
Zmiana terminu publikacji raportu rocznego za rok obrotowy 2024. - Content (PL)
|
Polish | HTML • 947 bytes |
Automate Your Workflow. Get a real-time feed of all Molecure S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Molecure S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Molecure S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
